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a b s t r a c t
Cell infection by parvoviruses requires that capsids be delivered from outside the cell to the cytoplasm,
followed by genome trafﬁcking to the nucleus. Here we microinject capsids into cells that lack receptors
and followed their movements within the cell over time. In general the capsids remained close to the
positions where they were injected, and most particles did not move to the vicinity of or enter the
nucleus. When 70 kDa-dextran was injected along with the capsids that did not enter the nucleus in
signiﬁcant amounts. Capsids conjugated to peptides containing the SV40 large T-antigen nuclear
localization signal remained in the cytoplasm, although bovine serum albumen conjugated to the same
peptide entered the nucleus rapidly. No effects of disruption of microﬁlaments, intermediate ﬁlaments,
or microtubules on the distribution of the capsids were observed. These results suggest that movement
of intact capsids within cells is primarily associated with passive processes.
& 2014 Published by Elsevier Inc.
Introduction
Cell infection by viruses that replicate in the nucleus involves
viral components being delivered into the cytoplasm and then
transfer of the genome to the nucleus, generally along with viral
proteins or capsid components (Greber and Fornerod, 2005; Marsh
and Helenius, 2006). The processing or transport of infecting
capsids or nucleocapsids within the cytoplasm, and the transport
of the genome to the vicinity of or into the nucleus can be complex
as the cytoplasm prevents the free diffusion of virus-sized parti-
cles (Lukacs et al., 2000; Seksek et al., 1997). For adenoviruses,
herpesviruses, and at least some retroviruses, viral proteins and
structures are actively transported within the cytoplasm to the
vicinity of the nucleus (Lagache et al., 2009b), while for other
viruses, including papillomaviruses and polyomaviruses endoso-
mal mechanisms are used to transport the capsids to the endo-
plasmic reticulum or other compartments (Engel et al., 2011;
Gruenberg, 2009; Sapp and Bienkowska-Haba, 2009).
The capsids of parvoviruses or adeno-associated viruses (AAVs)
bind receptors on the cell surface, enter the cells by receptor-
mediated endocytosis, and then trafﬁc within endosomes to the
microtubular organizing center (MTOC) (Ding et al., 2005;
Harbison et al., 2008; Harbison et al., 2009; Vendeville et al.,
2009). Release from endosomes appears to be quite slow and
requires the activity of a phospholipase A2 in the unique region of
the viral protein 1 (VP1), and many parvoviral capsids are retained
within endosomes for up to several hours (Farr et al., 2005; Zadori
et al., 2001). Expression of PLA2 in cells can alter the cellular
morphology (Deng et al., 2013). Because of the slow release of the
capsids, in studies of viral entry it can be difﬁcult to know whether
caspids being detected are within the cytoplasm or endosomes.
The roles of the different cytoskeleton elements in viral infec-
tion appear to be complex. In some studies infection has been
shown to depend on the presence of an intact microtubular
cytoskeleton, and capsids of autonomous parvoviruses (canine
parvovirus (CPV) and porcine parvovirus), and at least some
adeno-associated viruses (AAVs) have been suggested to be
trafﬁcked within the cytoplasm in association with the molecular
motor dynein (Kelkar et al., 2006, 2004; Suikkanen et al., 2003a).
Addition of peptides to AAV type-2 capsids that were predicted to
bind dynein light chain (LC8) also enhanced retrograde transport
in axons (Xu et al., 2005). However, other studies have suggested
that an intact cytoskeleton is less important for cell infection
(Hirosue et al., 2007), and it is unclear whether cytoplasmic
trafﬁcking of parvovirus capsids is an active trafﬁcking mechan-
ism, occurs by diffusion, or involves some combination of those
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processes. A role of intermediate ﬁlaments and vimentin in
infection by the MVM parvovirus has been reported in localization
of virions around the nucleus, and the ﬁlaments became rear-
ranged in cells that have taken up virions from the cell surface and
in many infected cells (Fay and Pante, 2013). After cells are infected
there may be extensive changes in the cellular architecture that
result from virus replication and expression of the viral NS1
protein (Nuesch et al., 2005).
When free in the cytoplasm parvovirus capsids may become
conjugated to ubiquitin, and in some cases the capsid proteins are
degraded by proteosomal systems (Boisvert et al., 2010; Ros and
Kempf, 2004; Yan et al., 2002). However, the effects reported vary
for different viruses, and while proteosomal inhibitors such as
MG138 enhance transduction by AAV type-2 or type-5 (Ding et al.,
2003; Yan et al., 2004), they inhibit infection by autonomous
parvoviruses (Ros and Kempf, 2004), and it may be difﬁcult to
distinguish direct and indirect effects of the drugs. AAV2 capsids
may also be modiﬁed by ubiquitin addition to surface exposed
tyrosines (Tyr), and mutating one or more of the several Tyr on the
capsid surface can enhance transduction due to alterations that
capsid modiﬁcation (Zhong et al., 2008a; Zhong et al., 2008b).
The processes of nuclear entry and exit of parvovirus capsids
are still not understood in detail, and may vary between viruses
and perhaps cell types. When capsids of autonomous parvoviruses
or AAV2 enter cells by receptor-mediated endosomal processes
only a low proportion are seen to enter the nucleus by microscopy
(Bantel-Schaal et al., 2002; Harbison et al., 2009; Seisenberger et
al., 2001). Puriﬁed CPV capsids microinjected into the cytoplasm of
cells and detected after cell ﬁxation remained in the cytoplasm for
more than 2 h (Vihinen-Ranta et al., 2002, 2000). Several AAV
serotypes may infect cells more rapidly, and higher proportions
were recovered in the nuclear-associated fractions a few hours
after uptake from the cell surface (Sonntag et al., 2006; Zhong et
al., 2008b). Both endosomal release and nuclear transport have
been associated with the release or exposure of the N-termini of
some or all of the 5 or 6 VP1s in each capsid, which contain both
the phospholipase A2 enzyme activity and sequences made up of
basic amino acids, similar to classic nuclear localization sequences
(NLS) (Sonntag et al., 2006; Vihinen-Ranta et al., 2002). The VP1
unique regions are usually sequestered within the capsid but
become exposed in the endosome (Farr and Tattersall, 2004;
Suikkanen et al., 2003b), and some would be on the outside of
capsids that enter the cytoplasm (Vihinen-Ranta et al., 2002).
After replication parvovirus capsids assemble in the nucleus,
and in many cases appear to be retained there. However, capsids
may also be trafﬁcked to the cytoplasm or even out of the cell. The
export of intact newly produced minute virus of mice (MVM)
capsids out of the nucleus occurred efﬁciently for some virus-cell
combinations, and was regulated by the phosphorylation of Ser
and Thr within the N-terminal sequence of VP2 exposed on the
outside of the newly produced full capsids (Maroto et al., 2004).
The process of nuclear export and cytoplasmic and extra-cellular
transport of the capsids was also associated with remodeling of
the actin cytoskeleton by the enzyme gelsolin, which is modiﬁed
by the viral NS1 protein (Bar et al., 2008).
Capsids in the cytoplasm are reported to directly alter the
structure of the nuclear envelope. When MVM capsids were
injected into the cytoplasm of Xenopus oocytes, they changed the
integrity and morphology of the nuclear envelope as seen by
electron microscopy, with damage particularly to the outer nuclear
membrane (Au et al., 2010; Cohen and Pante, 2005). When
puriﬁed capsids were added to digitonin-permeabilized ﬁbroblasts
the nuclear envelope morphology changed to show rufﬂes and
patches, as detected by staining for Lamin A/C (Cohen et al., 2006).
The nuclear breakdown was reported to involve enzymes involved
in nuclear changes that occur during mitosis, including protein
kinase C which acted on cdk-2, and which was acted on by
caspase-3 (Porwal et al., 2013).
Here we further examine the intracellular trafﬁcking of parvo-
viral capsids by examining the distribution of capsids within the
cytoplasm of live cells after microinjection. Fluorescently labeled
capsids generally remained close to the location where they were
injected, with little movement even over periods of hours, and
similar effects were seen with unlabeled capsids. That localization
was not signiﬁcantly altered by changes in the structures of the
microﬁlaments or microtubules, or by the presence of intermedi-
ate ﬁlaments.
Results
Here we examined the locations and movement of ﬂuores-
cently labeled virus capsids after injection into live cells, and
compared the results to those seen for unlabeled capsids in cells
that were ﬁxed after various times of incubation. Capsids were
labeled with Alexa488 or Alexa594 and were in the form of single
particles as described previously (Harbison et al., 2009). Initial
studies showed no obvious differences in the distribution or
movement of full or empty capsids (results not shown), and most
studies were conducted with full particles, which represent the
infectious virions.
We initially examined the distribution of capsids in feline NLFK
cells which express feline transferrin receptor type-1 (TfR) and
which bind and endocytose the virus, as well as within TRVb cells,
which are derived from CHO cells and which lack the TfR and
which do not bind viruses. The latter cells are efﬁciently infected
when expressing the feline TfR from a plasmid (Goodman et al.,
2010; Parker et al., 2001), indicating that the cytoplasmic and
nuclear transport processes required for infection are functional.
When capsids were released from the microinjection needle near
NLFK cells some were subsequently found on the surface and
ﬁlopodia of the cells, indicating that they bound receptors and
were endocytosed (Fig. 1A), so that using those cells would show
both injected and endocytosed capsids. However, receptor-
negative TRVb cells showed no evidence of surface bound virus
under the same conditions (Fig. 1B), and those were therefore used
for the remainder of these studies.
When ﬂuorescently labeled CPV capsids were injected into the
cytoplasm of live NLFK or TRVb cells they remained near the
position of injection for between 2 min and 1 h, with little move-
ment being observed (Fig. 1A and B). Twenty nanometer diameter
Cy5-labeled polystyrene nanospheres injected into TRVb cells also
showed little movement within the cytoplasm (Fig. 1C).
Previous studies have indicated that parvovirus capsids in the
cytoplasm can alter the nuclear morphology and nuclear envelope
integrity (Au et al., 2010; Cohen et al., 2006; Cohen and Pante,
2005). Cells expressing Lamin A/C-GFP were injected with
Alexa594-labeled full capsids (Fig. 2A) or with unlabeled capsids
(Fig. 3A,B), and examined using wideﬁeld and confocal micro-
scopy. The capsids remained near where they were injected
(Fig. 2A) with only a small proportion becoming localized adjacent
to the nuclear envelope (Figs. 2A and 3A,B). Some of the virus-
injected cells showed subtle changes in the distribution of Lamin
A/C that were not seen in the non-injected cells or in cells injected
with labeled BSA (Fig. 2B). When Alexa488-70 kDa dextran was
injected into the cytoplasm it mostly remained in that location
after 1.5–2 h with limited movement into the nucleus (Fig. 4A).
When injected along with capsids the 70 kDa dextran entered the
nucleus at similar rates as in the absence of capsids (Fig. 4B).
Capsids were conjugated to NLS peptides, with an average of
5 or 28 peptides attached to each capsid in two different
conjugated preparations. Peptide conjugated capsids were injected
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into cells and incubated at 37 1C, and then the capsids detected
using antibody staining after ﬁxing the cells. Most of the capsids
remained in the cytoplasm, while a few became localized within
the nucleus (Fig. 5A,B). As a control we injected BSA conjugated to
the same NLS peptide, and that entered the nucleus very quickly,
mostly in less than 30 min (Fig. 5C).
Labeled capsids injected into cells expressing GFP-actin did not
show any speciﬁc association of particles with the actin ﬁlaments,
and after incubating the injected cells for 1 h and then adding
cytochalasin only minor changes in the distribution of the particles
were seen (Fig. 6). In cells expressing YFP-tubulin some particles
appeared to be aligned with the microtubules, but addition of
nocodazole to the cells after incubating for 1 h did not result in
signiﬁcant changes in the capsid distribution (Fig. 7A). When the
microtubules were stabilized with Paclitaxel before injection of
virus, particles became distributed in similar patterns to those
seen in untreated cells (Fig. 7B). We examined wildtype and
vimentin –ve SW13 cells for the distribution of capsids after
injection (Fig. 8A and B), and saw similar distributions of the
particles, and the injected particles also did not signiﬁcantly alter
the distribution of the vimentin in the cells (Fig. 8C).
Discussion
Here we examine the localization of labeled capsids after
microinjection to cells, and followed their distribution during
subsequent incubations. While microinjection is an artiﬁcial
means of introducing virions into the cytoplasm or nucleus, these
studies provide additional information about this step of the
capsid-cell interaction that is difﬁcult to observe when capsids
are taken up through receptor-mediated processes due to the
difﬁculty of distinguishing between capsids within the various
endosomes and those that were free in the cytoplasm. In most
cases the capsids remained close to the site of injection for
1–2 h at 37 1C, while as expected labeled BSA or dextran became
Fig. 1. Distribution of Alexa594-labeled full CPV capsids or 20 nm Cy5-labeled polystyrene microspheres after injection into the cytoplasm of cells, with images collected
after incubation at 37 1C as indicated. In each ﬁeld some cells are injected, while others were left as non-injected controls. Feline NLFK cells express functional receptors,
while TRVb cells are receptor deﬁcient. (A) CPV capsids injected into NLFK cells, (B) CPV capsids in TRVb cells, (C) 20 nm Cy5 microbeads in TRVb cells.
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distributed throughout the cytoplasm within a few minutes. The
relative lack of capsid movement is likely related to their size and
to the tight packing of the cytoplasm, and we showed that 20 nm
diameter Cy5-labeled polystyrene nanospheres also showed little
movement after injection under the same conditions. Previous
studies of nanoparticle movement in the cytoplasm of cells have
showed a strong dependence on the diameter of the particle, with
those of 25 nm diameter or greater showing limited movement,
being restricted by the physical properties of the cytoplasm (Boulo
et al., 2007; Lagache et al., 2009a; Luby-Phelps, 2000; Novak et al.,
2009; Seksek et al., 1997; Wirtz, 2009). The 25 nm diameter
parvovirus particle is close to the size where diffusion was
observed in previous studies – reported to be below 40 nm –
although in this study we also saw limited movement of 20 nm
diameter nanoparticles (Fig. 1C).
To examine the possibility that the capsids are conﬁned or
transported by cytoskeletal components we examined their asso-
ciation with actin, tubulin, or vimentin. There was no clear
association with either the microtubules or microﬁlaments, and
nocodazol, paclitaxel, or cytochalasin D treatment did not sub-
stantially alter the distribution of the injected capsids. These
results contrast with studies which have suggested that CPV
capsids are actively transported by cytoplasmic dynein (Kelkar
et al., 2006; Suikkanen et al., 2003a), but are consistent with
others that show no direct role of microtubules in the transduction
by AAV capsids (Hirosue et al., 2007). Here localization of the
capsids remained close to the positions where they were depos-
ited by the injection process, and there was little movement
during incubation at 37 1C. The capsid distribution seen differs
from those seen in studies where cells were ﬁxed at various times
after virus was added to the cells. During normal receptor-
mediated entry processes capsids are rapidly carried within
endosomes to the vicinity of the microtubule organizing center
(Aniento et al., 1993; Hirokawa, 1998), and so active long-distance
transport of free capsids in the cytoplasm is not necessarily
required. In previous studies the actin cytoskeleton inﬂuenced
the release from the cell of newly produced MVM particles, but the
effect was associated with alterations of vesicular transport and
not to direct effects on the virions (Bar et al., 2008).
MVM capsids injected into Xenopus ooctyes inﬂuenced the
nuclear envelope morphology as seen by electron microscopy,
and effects were also seen in digitonin-permeabilized ﬁbroblasts
incubated with virions, by activating enzymes involved in nuclear
envelope breakdown (Au et al., 2010; Cohen et al., 2006; Cohen
and Pante, 2005; Porwal et al., 2013). Here we show that capsids
microinjected into live cells do alter the nuclear morphology, as
seen in the distribution of Lamin A/C, but the virus in the
cytoplasm did not appear to enhance the nuclear entry of 70 kDa
dextran, and the virions did not obviously enter the nucleus in
greatly increased amounts. These results suggest that capsids do
not simply permeabilize the nucleus under the conditions of this
study, and the role any direct virus-nuclear interaction on infec-
tion remains unclear.
Three different sequences or structures have been reported to
inﬂuence nuclear trafﬁcking of parvoviral capsid proteins or
capsids. VP2 alone can enter the nucleus in an unassembled or
oligomeric form (Yuan and Parrish, 2001), perhaps by using a
structure that is formed when the protein trimerizes (Lombardo
et al., 2000). The N-terminal sequence of the VP2 protein and
phosphorylated Ser and Thr residues of the MVM control nuclear
Fig. 2. Distribution of microinjected (A) Alexa594-full CPV capsids (red) or (B) Alexa594-BSA (red) in TRVb cells expressing Lamin A/C-GFP (green), after various times of
incubation at 37 1C. The phase images of the same cells are also shown. The cells injected are enclosed by a white outline.
S.M. Lyi et al. / Virology 456-457 (2014) 342–352 345
Fig. 3. Distribution of unlabeled CPV capsids within cells after injection at different concentrations, with different nuclear stains. Cells were ﬁxed after 1 h incubation at
37 1C, and capsids were detected with anti-capsid antibody 8. The distribution of capsids injected at concentrations of (A) 5 mg/ml or (B) 50 mg/ml in cells expressing
Lamin A/C.
Fig. 4. Effect of co-injected capsids on the distribution of ﬂuorescent dextran in the cell. The dextran was injected alone (A) or along with capsids (B), and the cells then
incubated for 80 or 90 min at 37 1C.
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export of full capsids (Maroto et al., 2004). Sequences in the
N-terminal domain of VP1 that include a NLS-like motif can
become exposed to the outside of the capsid during endocytosis
(Cotmore et al., 1999; Cotmore et al., 2010; Riolobos et al., 2006;
Vihinen-Ranta et al., 2002). Here we saw only low amounts of
labeled virus entering the nucleus, even when conjugated to an
5 or 28 copies of an NLS peptide. The nuclear pore has a diameter
for free diffusion of 9 nm, but has been reported to allow
passage of particles of 30–40 nm in diameter (Labokha and
Fassati, 2013; Pante and Kann, 2002; Solmaz et al., 2013), suggest-
ing that the 25 nm diameter capsids could be trafﬁcked into the
nucleus by active processes. Alternatively, if the NLS is engaged by
α/β-importin complex this may alter the capsid distribution.
Infection clearly involves a series of coordinated steps, including
the release of the VP1 N-terminus and the 30-end of the viral DNA.
The nuclear entry processes may therefore show similarities to
those reported for other viral capsids, including adenovirus,
hepatitis B virus, and herpesviruses, which dock onto or close to
the nuclear pore in a partially disassembled form, allowing release
of the genome for transport into the nucleus, sometimes along
with accessory proteins (Krautwald et al., 2009; Pasdeloup et al.,
2009; Rabe et al., 2009; Schmitz et al., 2010; Trotman et al., 2001).
These results provide new information about the localization
and movement of parvovirus capsids in the cytoplasm of host cells,
and their interactions with the nucleus over periods of hours. The
capsids injected here do not recapitulate some of the conditions
encountered during normal cell entry, such as the low pH
exposure of receptor-bound capsids, but do show some processes
that determine the virus distribution within the cytoplasm. The
limited movement of the capsids observed here is likely not a
speciﬁc barrier to cell infection, as after endosomal transport the
incoming particles end up very close to the nucleus (Bantel-Schaal
et al., 2009; Harbison et al., 2009; Liu et al., 2013; Mani et al.,
2006; Suikkanen et al., 2002), from which position they should
readily reach the nuclear pore. This would therefore differ from
the infection pathways required for viruses such as herpesvirus
and HIV which enter through the plasma membrane and hence
need to traverse the entire cytoplasm. The data provides a
foundation for testing variables of capsid processing during
cytoplasmic and nuclear transport in future studies.
Materials and methods
Cells and viruses
Feline NLFK cells were grown in a 1:1 mixture of McCoy's 5A
and Liebovitz L15 media with 5% fetal bovine serum. CHO-derived
cells lacking transferrin receptor 1 (TRVb cells) (McGraw et al.,
1987) were grown in Ham's F12 medium containing 5% fetal
bovine serum. In some cases cells were transfected with plasmids
expressing green ﬂuorescent protein (GFP)-actin, yellow ﬂuores-
cent protein (YFP)-tubulin, or GFP-lamin-A/C. Transfected cells
were grown for 2 or 3 passages before use in these studies, or
positive cells were selected by growth in the presence of 400 μg/
ml of G418. SW13 cells that were vimentin þve or –ve were used
to study the role of intermediate ﬁlaments (Hedberg and Chen,
1986; Ho et al., 1998).
Viruses were derived from the infectious plasmid clone of CPV
type-2 (CPV-d) (Parrish, 1991). Plasmids were transfected into
NLFK cells and recovered viruses were titrated using TCID50 assays
(Parker and Parrish, 1997). Virus capsids were concentrated by
polyethylene glycol precipitation followed by sucrose gradient
centrifugation, then dialyzed against either PBS or 20 mM Tris–
HCl (pH 7.5) and stored at 4 1C (Agbandje et al., 1993; Nelson et al.,
2008).
Labeled proteins, capsids, and nanospheres
Bovine serum albumen (BSA) that was conjugated to both
rhodamine and to a large T-antigen nuclear localization sequence
(NLS) peptide was obtained from Sigma (St Louis, MO). Puriﬁed
Fig. 5. The effect of addition of NLS-peptides to CPV capsids, compared to BSA conjugated to the same peptide. TRVb cells were injected with NLS-conjugated capsids, then
the cells ﬁxed 60 min after injection and capsids detected with an antibody, while the nuclei were stained with DAPI. (A) and (B) The distribution of CPV capsids conjugated
with an average of 28 (A) or 5 (B) ﬂuorescene-NLS peptides per capsid, after injection into cells expressing Lamin A/C-GFP and incubation for 60 min. (C) BSA conjugated to
ﬂuorescene-NLS peptide and injected into TRVb cells, then incubated at 37 1C. Images were collected at the indicated times after injection.
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BSA or capsids were conjugated with Alexa488 or Alexa594
(Invitrogen, San Diego, CA) using methods recommended by the
supplier. Brieﬂy, full or empty CPV capsids at 1 mg/ml in 0.1 M
bicarbonate buffer (pH 8.3) were conjugated with Alexa dye for 1 h
at 22 1C, and then 150 mM (ﬁnal) hydroxylamine was added to
neutralize the labeling reaction. The labeled proteins were sepa-
rated from the free dye by passage through a P10 chromatography
column (Millipore, Billerica, MA). An NLS peptide that included
ﬂuorescene was obtained from New England Peptides (Gardner,
MA), and had the sequence Ac-PKKKRKVEDPYGK(FITC)GC-OH. That
peptide was conjugated to BSA or to capsids by the hetero-bifunctional
reagent, sulfosuccinimidyl 4-[N-maleimidomethyl]cyclohexane-1-car-
boxylate (Sulfo-SMCC) as recommended by the manufacturer (Thermo
Scientiﬁc, Rockford, IL). Cy5 labeled polystyrene nanospheres (20 nm
Fig. 6. (A) The distribution of Alexa594-CPV full capsids (red) injected into cells expressing Actin-GFP (green), and incubated at 37 1C for various times. Cytochalasin (Cyto)
was added after 60 min incubation, and the cells incubated for a further 30 min. Images on the right of the 5, 30 and 60 min times show a higher magniﬁcation view of the
capsid distribution on the cytoplasm. (B) Tracking the movement of individual particles in the absence or presence of cytochalasin. (C) Plots showing the measured
differences in the movement of the capsids in the presence or absence of cytochalasin.
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diameter) were purchased from Fluorophorex (Fall River, MA). Vimen-
tine in cells was stained with mouse monoclonal anti-Vimentin Clone
V9 antibody (V6630, Sigma), and detected with goat anti-mouse
Alexa488.
Cell microinjection
NLFK or TRVb cells in medium lacking phenol red were
microinjected with 6 nl volumes using an Eppendorf Femtojet
micromanipulator and InjectMan NI2 microinjector (Eppendorf,
Hauppauga, NY), using needles prepared with a P-97 micropipette
puller (Sutter Instrument Co., Novato, CA). Samples of capsids,
proteins, or nanospheres were prepared in microinjection buffer
(48 mM K2HPO4, 4.5 mM KH2PO4, 14 mM NaH2PO4, pH7.2),
injected into cells, and then the cells were incubated at 37 1C for
varying times. Where labeled materials were injected, or where
GFP-expression was present, the cells seeded in Falcon 50 mm
gridded dishes (MatTek, Ashland, MA) or in Delta T4 culture dishes
(Bioptechs, Butler, PA) in a 37 1C warming chamber with a stage
warmer (World Precision Instruments, Sarasota, Fl). The cells were
examined for ﬂuorescence and images collected at different
intervals. In other cases the cells were incubated at 37 1C after
injection, ﬁxed after various times with 4% paraformaldehyde,
then the virus detected by staining with Alexa Fluor 594-labeled
rabbit or mouse anti-capsid monoclonal antibody 8. In some
experiments, the nuclear DNA of the cells was stained with DAPI,
or the nuclear pores were stained with antibody Mab414 (Abcam,
Cambridge, MA) that recognizes the conserved FXFG repeats in
nucleoporins, followed by Alexa Fluor 488-labeled goat anti-
mouse IgG. Some cells were treated 30 min before or at various
times after injection with 10 mM cytochalasin D (C8273), 20 mM
nocodazole (M1404), or 100 nM Paclitaxel (T7191) (all from
Sigma).
Microscopic analysis
Cells were examined using wide ﬁeld microscopy with a Nikon
TE300 microscope and a Hamamatsu OrcaER charge-coupled-
device camera or by confocal imaging with a Zeiss LSM510 micro-
scope. Images were prepared using either Simple PCI software
Fig. 7. Distribution of microinjected Alexa594-CPV full capsids (red) followed in live cells expressing YFP-tubulin (green), and in some cases subjected to various treatments.
(A) Injected cells incubated at 37 1C for up to 1 h, as indicated. Nocodazole was added to the cells after 60 min incubation, and then the cells incubated for a further 30 min.
(B) Capsids in cells that had been pretreated with Paclitaxel (taxol) for 2 h at 37 1C.
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(Hamamatsu, Sewickley, Pa), Image J software (US National Insti-
tutes of Health, Bethesda, MD), ZEN 2010 (Zeiss, Thornwood, NY)
and/or Adobe Photoshop (Adobe, San Jose, CA).
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